SANXING(SH:601567) Zheng Quan Shi Bao Wang·2025-10-30 13:13Core Viewpoint - Samsung Medical (601567) experienced a significant drop in stock price, with a daily decline of 9.28%, leading to a trading halt and notable net selling by institutions and the Shanghai-Hong Kong Stock Connect [2][3]. Trading Activity - The stock had a turnover rate of 4.90% and a total trading volume of 1.585 billion yuan, with a price fluctuation of 4.27% throughout the day [2]. - Institutional investors net sold 112 million yuan, while the Shanghai-Hong Kong Stock Connect recorded a net sell of 103 million yuan [2]. - A total of 8 institutional trading seats were involved, with combined buying of 210 million yuan and selling of 322 million yuan, resulting in a net sell of 112 million yuan [2]. Fund Flow - The stock saw a net outflow of 197 million yuan in principal funds, with large orders contributing to a net outflow of 136 million yuan and 61.036 million yuan from big orders [2]. - Over the past five days, the total net outflow of principal funds reached 258 million yuan [2]. Financial Performance - For the first three quarters, the company reported a revenue of 11.08 billion yuan, reflecting a year-on-year growth of 6.19%, while net profit decreased by 15.85% to 1.528 billion yuan [3]. - Two institutions rated the stock as a buy in the last five days, with the highest target price set at 32.00 yuan by CICC [3].